Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Addiction. 2019 Jun 24;114(9):1593–1601. doi: 10.1111/add.14661

Table 3.

Association between medical marijuana laws (MML) and marijuana treatment admissions by pregnant women per 100,000 women, potential pathways

Ease of Access Tx Referral Source
Legal Dispensaries Full sample Youth Subsample Adult Subsample Healthcare Provider Subsample Criminal Justice Subsample Other Sources Subsample
MML 4.11*** 0.32 5.50*** 1.12* 0.6 2.55**
[1.24, 6.99] [−3.01, 3.65] [1.52, 9.47] [−0.13, 2.37] [−0.51, 1.71] [0.48, 4.63]
Dispensary 6.37*
[−0.97, 13.70]
Mean 14.34 6.36 15.77 2.74 4.03 7.22
N 606 606 606 602 602 602

Source: Treatment Episode Data Set Admissions, 2002–2014.

Notes: Coefficients are based on a difference-in-differences approach that estimates changes in outcomes and accounts for controls. Controls include state unemployment rates, beer excise tax rates, Medicaid income eligibility thresholds for pregnant women, the Affordable Care Act Medicaid expansions, pain clinic laws, prescription drug monitoring program operations and mandates, and recreational marijuana laws. The dispensary indicator captures the differential effect of MMLs in states with operational and legally protected dispensaries. The youth subsample includes marijuana treatment admissions by women ages 12 to 17 and the adult subsample includes marijuana treatment admissions by women ages 18 to 49. The mean captures average outcomes 2 years prior to MML implementation for MML states. Confidence intervals are in parentheses.

***

p<0.01,

**

p<0.05,

*

p<0.1